+987.9%
MRNA vs ADVB
-76.7%
+1,064.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ADVB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -4.5% | +17.7% | +13.0% |
| 7D | +20.6% | -29.5% | +50.2% | +19.9% |
| 30D | +27.1% | -66.9% | +94.0% | +23.8% |
| 3M | +353.4% | -73.7% | +427.1% | +339.1% |
| 6M | +446.3% | -64.8% | +511.0% | +418.3% |
| YTD | +776.2% | -64.0% | +840.2% | +703.2% |
| 1Y | +987.9% | -77.0% | +1,064.9% | +1,007.8% |
| All | +987.9% | -76.7% | +1,064.6% | +1,007.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ADVB.
Daily Out/Under-Performance
Portfolio return minus ADVB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ADVB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ADVB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling